China's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

I. INTRODUCTION
Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS
Mental Illness Drugs Industry Structure
Market Size
Market Growth Drivers
Mental Illness Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND
Overview
Sales Volume of Pharmaceuticals by Region
Mental Illness Drugs Sales Volume
Haloperido
Chlorpromazine
Ziprasidone
Olanzapine
Clozapine
Quetiapine
Aripiprazole
Risperidone
Fluoxetine
Other Mental Illness Drugs
Mental Illness Imports and Exports
Mental Illness Drugs Imports
Mental Illness Exports
Pricing Trend

V. CHINA MENTAL ILLNESS DRUGS MARKETS OUTLOOK
Mental Illness Drugs Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospitals Beds
Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS
China Market Entry Overview
China’s Distribution System
Mental Illness Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. MENTAL ILLNESS DRUGS PRODUCER DIRECTORY
Mental Illness Drugs Producer Profiles and Directory
Major End-Users

LIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS
Mental Illness Drugs Sales Volume
Major Producer Facility Location
Major Mental Illness Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investment in China
IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND
Mental Illness Drugs Sales Volume
Demand of Mental Illness Drugs by Region in 2008
Haloperido Sales Volume
Chlorpromazine Sales Volume
Ziprasidone Sales Volume
Olanzapine Sales Volume
Clozapine Sales Volume
Quetiapine Sales Volume
Aripiprazole Sales Volume
Risperidone Sales Volume
Fluoxetine Sales Volume
Other Mental Illness Drugs Sales Volume
China Mental Illness Drugs Imports and Exports
V. CHINA MENTAL ILLNESS DRUGS MARKETS OUTLOOK
Total Mental Illness Drugs Sales Volume by Market
Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS
I. INTRODUCTION
China’s Mental Illness Drugs Output, Capacity, Demand
II. BUSINESS ENVIRONMENT
China’s GDP and Growth Rate
Industrial Output by Ownership
China’s Imports and Exports
III. MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS
Mental Illness Drugs Sales Volume in China
IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND
Mental Illness Drugs Sales Volume in China
Haloperido Sales Volume
Chlorpromazine Sales Volume
Ziprasidone Sales Volume
Olanzapine Sales Volume
Clozapine Sales Volume
Quetiapine Sales Volume
Aripiprazole Sales Volume
Risperidone Sales Volume
Fluoxetine Sales Volume
Total mental Illness Drugs Imports and Exports
V. MENTAL ILLNESS DRUGS MARKETS OUTLOOK
Mental Illness Drugs Sales Volume by Market in 2008
VI. MARKETING STRATEGIES
China’s Distribution Channel